Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Short Interest Update

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the recipient of a large growth in short interest in January. As of January 15th, there was short interest totalling 12,200 shares, a growth of 144.0% from the December 31st total of 5,000 shares. Based on an average trading volume of 5,300 shares, the days-to-cover ratio is presently 2.3 days.

Clinuvel Pharmaceuticals Trading Down 1.3 %

Shares of OTCMKTS CLVLY traded down $0.10 during trading on Wednesday, reaching $7.50. The company had a trading volume of 290 shares, compared to its average volume of 3,139. Clinuvel Pharmaceuticals has a 52 week low of $6.80 and a 52 week high of $11.40. The business’s 50 day moving average price is $7.83 and its 200-day moving average price is $8.95.

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).